The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preclinical efficacy studies using HuMax-Axl-ADC, a novel antibody-drug conjugate targeting Axl-expressing solid cancers.
 
Esther CW Breij
Employment - Genmab
Patents, Royalties, Other Intellectual Property - Genmab (Inst)
 
Sandra Verploegen
Employment - Genmab
Patents, Royalties, Other Intellectual Property - Genmab (Inst)
 
Andreas Lingnau
Employment - Genmab
Patents, Royalties, Other Intellectual Property - Genmab (Inst)
 
Edward N van den Brink
Employment - Genmab
Patents, Royalties, Other Intellectual Property - Genmab (Inst)
 
Maarten Janmaat
Employment - Genmab
Patents, Royalties, Other Intellectual Property - Genmab (Inst)
 
Mischa Houtkamp
Employment - Genmab
Patents, Royalties, Other Intellectual Property - Genmab (Inst)
 
Wim Bleeker
Employment - Genmab
Patents, Royalties, Other Intellectual Property - Genmab (Inst)
 
David Satijn
Employment - Genmab
 
Paul Parren
Employment - Genmab
Stock and Other Ownership Interests - Genmab
Consulting or Advisory Role - Immunogen
Patents, Royalties, Other Intellectual Property - Genmab (Inst); Integrated Biotherapeutics